Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Genome Plasticity and B cells
Group leader
Saïd Aoufouchi
Pavillon de recherche 2, Level 3
Theme
Genome Plasticity and B cell
This group belongs to the group "TLS Polymerases: Genome Plasticity and Cancers"
Our group associates researchers working on the coordination and regulation of DNA repair processes in B lymphocyte following AID expression and on the role of AID in B cell tumourigenesis.
To create the necessary diversity and specificity, the immune system uses two successive and regulated genomic alterations. Early in B cell development, the antigen receptors (B cell receptor or antibody expressed at B cell surface) are constructed by V(D)J recombination, a site-specific process initiated by the lymphocyte specific proteins RAG1 and RAG2. The mechanism by which V(D)J recombination occurs is clearly established, involving DNA double-strand break intermediaries which are resolved by the ubiquitous non-homologous end-joining DNA repair machinery. However, in response to antigens, mammalian B cells undergo a new series of specialised DNA modifications resulting in the production of specific antibodies with both high affinity and the adequate effector function. These modifications are somatic hypermutations (SHM), in which single base pair changes are preferentially introduced in the variable domain of immunoglobulin (Ig) with a very high frequency, and class switch recombination (CSR), in which recombination between switch sequences leads to a change of antibody isotype. These processes depend on activation-induced cytidine deaminase (AID), a key enzyme expressed only in B cells from secondary lymphoid organs upon antigen encounter. AID is a cytidine deaminase acting directly on DNA. To generate SHM starting from U:G mismatches, AID participates in concert with the other partners of the “mutasome” including mismatch repair proteins (Msh2, Msh6 and Exo1), mono-ubiquitinated PCNA and the translesion synthesis error prone polymerases pol eta and rev1. Immunoglobulin class switch recombination is also initiated by AID. U:G mismatches and abasic sites (following the dU removal by uracil DNA glycosylase (Ung2)) are processed to produce lesions that recruit and activate DNA damage response proteins including Ataxia-telangiectasia mutated (ATM), histone H2AX, Nijmegen breakage syndrome 1 (Nbs1), and p53 binding protein 1 (53BP1).
In general the presence of uracil on DNA is recognised and efficiently removed and replaced by the correct base by the base excision repair machinery. Surprisingly, in activated B cells during physiological Ig gene SHM, the uracils generated by AID seem to be actively ignored and used to promote more mutations, in particular at A-T residues, which account for half of the mutations generated in vivo. AID activity therefore seems to be able not only to generate dU residues at the Ig loci, but also to activate error-prone repair pathways that convert it to mutation.
The group’s project aims to address and to study how the B cell machinery coordinates two very challenging processes: First, the obligation to shape and adapt quickly and efficiently the receptor to a given antigen (to increase the affinity and specificity) by introducing a high rate of mutations in the Ig variable domain and by initiating DNA breaks for class switch recombination. Second, providing the necessary protection of the rest of the genome from both deleterious mutations due to aberrant SHM and translocations associated with aberrant CSR. Although many of the enzymes that are involved have been identified in the past few years, some of the mutational factors have yet to be discovered, and there is still much to be learned about how they are coordinated and targeted to the Variable and Switch regions. Finally, the group, in collaboration with medical doctors from Gustave Roussy haematology department will address the role of the “mutasome” machinery in the onset of human germinal centres B cell non-Hodgkin's lymphomas.
Publications
Major publications since 2009
- Xavier Renaudin, Jean-Hugues Guervilly, Said Aoufouchi, and Filippo Rosselli.Proteome-wide analysis unveils a FANCA-modulated neddylation signaling pathway involved in CXCR5 membrane trafficking and cell mobility.
- J Cell Sci. 2014 Aug 15;127(Pt 16):3546-54. doi: 10.1242/jcs.150706. Epub 2014 Jul 11.
- Nguyen TV, Riou L, Aoufouchi S*, Rosselli F*. J Exp Med. Fanca deficiency reduces A/T transitions in somatic hypermutation and alters class switch recombination junctions in mouse B cells. 2014 Jun 2;211(6):1011-8. doi: 10.1084/jem.20131637. Epub 2014 May 5. (* corresponding authors)
- Gineau L, Cognet C, Kara N, Lach FP, Dunne J, Veturi U, Picard C, Trouillet C, Eidenschenk C, Aoufouchi S, Alcaïs A, Smith O, Geissmann F, Feighery C, Abel L, Smogorzewska A, Stillman B, Vivier E, Casanova JL, Jouanguy E. J Clin Invest.
- Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. 2012 Mar 1;122(3):821-32. doi: 10.1172/JCI61014. Epub 2012 Feb 22.
- S, Aoufouchi S, Weill JC, Reynaud CA. AID and partners: for better and (not) for worse.
- Storck.Curr Opin Immunol. 2011 Jun;23(3):337-44. Epub 2011 Mar 24. Review
- Faili A, Stary A, Delbos F, Weller S, Aoufouchi S, Sarasin A, Weill JC, Reynaud CA.
- A backup role of DNA polymerase kappa in Ig gene hypermutation only takes place in the complete absence of DNA polymerase eta.
- J Immunol. 2009 May 15;182(10):6353-9.
- ATM localization and gene expression in the adult mouse eye.. 2009;15:393-416. Epub 2009 Feb 20
- Reynaud CA, Delbos F, Faili A, Guéranger Q, Aoufouchi S, Weill JC Competitive repair pathways in immunoglobulin gene hypermutation..
- Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):613-9. Review
- Gueranger Q, Stary A, Aoufouchi S, Faili A, Sarasin A, Reynaud CA, Weill JC. Role of DNA polymerases eta, iota and zeta in UV resistance and UV-induced mutagenesis in a human cell line.
- DNA Repair (Amst). 2008 Sep 1;7(9):1551-62. Epub 2008 Jul 21.
- Aoufouchi S, Faili A, Zober C, D'Orlando O, Weller S, Weill JC, Reynaud CA. Proteasomal degradation restricts the nuclear lifespan of AID.
- J Exp Med. 2008 Jun 9;205(6):1357-68. Epub 2008 May 12.
Lab members
Lab members
- Saïd AOUFOUCHI – Research Scientist – Group Leader
- Dorine BONTE – Assistant professeur -Paris Sud University
- Léticia KOCH- LERNER- Post doc
- Morwenna Le GUILLOU – Engineer assistant Paris Sud University
- Céline DECAUX- Master2 trainer programm UPMC
- Charlène TRILLeaud - Master1 trainer programm UPMC
- Roukia BELGADAR Undergraduate student –UPMC